$1.33 Billion is the total value of Hudson Executive Capital LP's 10 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DB | DEUTSCHE BANK A Gnamen akt | $844,667,000 | -2.0% | 67,389,676 | 0.0% | 63.38% | +4.6% | |
| TVTY | TIVITY HEALTH INC | $126,788,000 | +14.7% | 4,795,310 | 0.0% | 9.51% | +22.3% | |
| CTLP | Buy | CANTALOUPE INC | $107,469,000 | -16.9% | 12,102,400 | +0.9% | 8.06% | -11.3% |
| VRAY | Buy | VIEWRAY INC | $85,541,000 | -19.7% | 15,524,623 | +5.1% | 6.42% | -14.3% |
| NTRA | NATERA INC | $54,996,000 | -16.2% | 588,886 | 0.0% | 4.13% | -10.6% | |
| EHTH | EHEALTH INC | $38,276,000 | -37.0% | 1,501,002 | 0.0% | 2.87% | -32.8% | |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $36,778,000 | +42.4% | 2,402,253 | +29.9% | 2.76% | +52.0% |
| TALK | Buy | TALKSPACE INC | $22,341,000 | -40.8% | 11,340,600 | +9.7% | 1.68% | -36.9% |
| LSYN | LIBERATED SYNDICATION INC | $8,544,000 | +7.9% | 2,400,000 | 0.0% | 0.64% | +15.1% | |
| BLEND LABS INCcl a | $7,340,000 | -45.5% | 1,000,000 | 0.0% | 0.55% | -41.9% | ||
| Exit | EG ACQUISITION CORP*w exp 05/28/2028 | $0 | – | -80,949 | -100.0% | -0.00% | – | |
| Exit | EG ACQUISITION CORP | $0 | – | -242,849 | -100.0% | -0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
| EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
| NATERA INC | 15 | Q4 2022 | 4.6% |
| CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
| VIEWRAY INC | 14 | Q2 2023 | 8.2% |
| ATRICURE INC | 13 | Q3 2019 | 20.9% |
| CIT GROUP INC | 11 | Q2 2018 | 26.4% |
| TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
| CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
| CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
| Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
| Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
| eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
| Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
| USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
| Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
| TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
| EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
| Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-21 |
| 4 | 2024-02-21 |
| SC 13D/A | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-07-21 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.